Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    75.0%

    Based on 3 completed trials

    Completion Rate
    75%(3/4)
    Active Trials
    1(17%)
    Results Posted
    67%(2 trials)
    Terminated
    1(17%)

    Phase Distribution

    Phase 1/2
    1
    17%
    Early Phase 1
    2
    33%
    Not Applicable
    3
    50%

    Phase Distribution

    2

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution6 total trials
    Early Phase 1First-in-human
    2(33.3%)
    Phase 1/2Combined phases
    1(16.7%)
    N/ANon-phased studies
    3(50.0%)

    Highest Phase Reached

    Phase 1/2

    Trial Status & Enrollment

    Completion Rate

    60.0%

    3 of 5 finished

    Non-Completion Rate

    40.0%

    2 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    6

    all time

    Status Distribution
    Active(1)
    Completed(3)
    Terminated(2)

    Detailed Status

    Completed3
    Terminated1
    Withdrawn1
    Recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    6
    Active
    1
    Success Rate
    75.0%
    Most Advanced
    Phase 1/2

    Trials by Phase

    Early Phase 12 (33.3%)
    Phase 1/21 (16.7%)
    N/A3 (50.0%)

    Trials by Status

    terminated117%
    withdrawn117%
    completed350%
    recruiting117%

    Recent Activity

    1 active trials
    Showing 5 of 6
    recruitingnot_applicable

    Neuromodulation and Neurorehabilitation for mTBI

    NCT03819608
    terminatednot_applicable

    QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

    NCT03576768
    completedearly_phase_1

    iTBS Methods and Motor Cortex Excitability

    NCT03584438
    completedearly_phase_1

    Developing rTMS Treatment Strategies for Pain in Opiate Dependence

    NCT03576781
    withdrawnnot_applicable

    Electrophysiological Investigation and rTMS Intervention of Ambulatory Central Processing of Freezing of Gait in Parkinson's Disease

    NCT01884493
    View all 6 trials

    Clinical Trials (6)

    Showing 6 of 6 trials
    NCT03819608Not Applicable

    Neuromodulation and Neurorehabilitation for mTBI

    Recruiting
    NCT03576768Not Applicable

    QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt

    Terminated
    NCT03584438Early Phase 1

    iTBS Methods and Motor Cortex Excitability

    Completed
    NCT03576781Early Phase 1

    Developing rTMS Treatment Strategies for Pain in Opiate Dependence

    Completed
    NCT01884493Not Applicable

    Electrophysiological Investigation and rTMS Intervention of Ambulatory Central Processing of Freezing of Gait in Parkinson's Disease

    Withdrawn
    NCT00753519Phase 1/2

    Transcranial Magnetic Stimulation to Treat Parkinson's Disease

    Completed

    All 6 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    6